Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Nicergoline is an antagonist of α1-adrenergic receptors (α1-ARs).1 It binds to α1-ARs in rat brain membranes (Ki = 12.5 nM) and inhibits α1-AR agonist-induced contractions in endothelium-denuded isolated rat aortic rings and perfused mesenteric vascular beds (pA2s = 8.6 and 11.1, respectively). In vivo, nicergoline (0.5 µg/kg per minute, i.v.) inhibits pressor responses induced by the α1-AR agonist cirazoline (Item No. 21791) in pithed rats. Nicergoline (32 mg/kg) improves post-ischemic glutamate uptake and reduces neuronal cell death and mortality in a rat model of global brain ischemia induced by mild hyperthermia.2 It also increases corneal NGF levels and accelerates corneal wound healing in a rat model of ocular injury.3
WARNING This product is not for human or veterinary use.
1. Selective blockade by nicergoline of vascular responses elicited by stimulation of alpha1A‐adrenoceptor subtype in the rat. Fundam. Clin. Pharmacol. 13(1), 50-58 (1999).
2. Nicergoline enhances glutamate re-
3. Effects of nicergoline on corneal epithelial wound healing in rat eyes. Invest. Ophthalmol. Vis. Sci. 50(2), 621-625 (2009).